Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIMABOTULINUMTOXINB vs RIOCIGUAT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIMABOTULINUMTOXINB vs RIOCIGUAT: Safety Overview

Metric RIMABOTULINUMTOXINB RIOCIGUAT
Total FAERS Reports 176 18,268
Deaths Reported 38 5,380
Death Rate 21.6% 29.5%
Hospitalizations 35 7,951
Average Patient Age 59.0 yrs 63.9 yrs
% Female Patients 68.6% 70.6%
FDA Approval Date N/A Oct 8, 2013
Manufacturer Solstice Neurosciences, LLC Bayer HealthCare Pharmaceuticals Inc.
Route INTRAMUSCULAR ORAL
Marketing Status N/A Prescription